These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19118735)

  • 1. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.
    Schanzer A; Mega J; Meadows J; Samson RH; Bandyk DF; Conte MS
    J Vasc Surg; 2008 Dec; 48(6):1464-71. PubMed ID: 19118735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia.
    Schanzer A; Goodney PP; Li Y; Eslami M; Cronenwett J; Messina L; Conte MS;
    J Vasc Surg; 2009 Oct; 50(4):769-75; discussion 775. PubMed ID: 19628361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program.
    Causey MW; Ahmed A; Wu B; Gasper WJ; Reyzelman A; Vartanian SM; Hiramoto JS; Conte MS
    J Vasc Surg; 2016 Jun; 63(6):1563-1573.e2. PubMed ID: 27036309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Year Outcomes of the OLIVE Registry, a Prospective Multicenter Study of Patients With Critical Limb Ischemia: A Prospective, Multi-Center, Three-Year Follow-Up Study on Endovascular Treatment for Infra-Inguinal Vessel in Patients With Critical Limb Ischemia.
    Iida O; Nakamura M; Yamauchi Y; Fukunaga M; Yokoi Y; Yokoi H; Soga Y; Zen K; Suematsu N; Inoue N; Suzuki K; Hirano K; Shintani Y; Miyashita Y; Urasawa K; Kitano I; Tsuchiya T; Kawamoto K; Yamaoka T; Uesugi M; Shinke T; Oba Y; Ohura N; Uematsu M; Takahara M; Hamasaki T; Nanto S;
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1493-1502. PubMed ID: 26404203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular Therapy Versus Bypass Surgery as First-Line Treatment Strategies for Critical Limb Ischemia: Results of the Interim Analysis of the CRITISCH Registry.
    Bisdas T; Borowski M; Stavroulakis K; Torsello G;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2557-2565. PubMed ID: 28007205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia.
    Chung J; Modrall JG; Ahn C; Lavery LA; Valentine RJ
    J Vasc Surg; 2015 Jan; 61(1):162-9. PubMed ID: 25073577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes after infrainguinal bypass grafting for critical limb ischaemia in patients with dialysis-dependent end-stage renal failure.
    Kodama A; Sugimoto M; Kuma S; Okazaki J; Mii S; Komori K
    Eur J Vasc Endovasc Surg; 2014 Dec; 48(6):695-702. PubMed ID: 25281532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.
    Stavroulakis K; Borowski M; Torsello G; Bisdas T;
    J Vasc Surg; 2017 Nov; 66(5):1534-1542. PubMed ID: 28807382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Comprehensive Risk Assessment for Bypass (CRAB) facilitates efficient perioperative risk assessment for patients with critical limb ischemia.
    Meltzer AJ; Graham A; Connolly PH; Meltzer EC; Karwowski JK; Bush HL; Schneider DB
    J Vasc Surg; 2013 May; 57(5):1186-95. PubMed ID: 23375435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemia.
    Wijnand JGJ; van Koeverden ID; Teraa M; Spreen MI; Mali WPTM; van Overhagen H; Pasterkamp G; de Borst GJ; Conte MS; Gremmels H; Verhaar MC
    J Vasc Surg; 2020 Mar; 71(3):869-879. PubMed ID: 31564582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia.
    Chang CK; Scali ST; Feezor RJ; Beck AW; Waterman AL; Huber TS; Berceli SA
    J Vasc Surg; 2014 Dec; 60(6):1554-64. PubMed ID: 25043889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of survival and major amputation after peripheral endovascular intervention for critical limb ischemia.
    Vierthaler L; Callas PW; Goodney PP; Schanzer A; Patel VI; Cronenwett J; Bertges DJ;
    J Vasc Surg; 2015 Sep; 62(3):655-64.e8. PubMed ID: 26215708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multicenter Predictive Score for Amputation-Free Survival for Patients Operated on with an Heparin-Bonded ePTFE Graft for Critical Limb Ischemia.
    Dorigo W; Piffaretti G; Pulli R; Castelli P; Pratesi C;
    World J Surg; 2017 Jan; 41(1):306-313. PubMed ID: 27473129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective Performance Goals for Surgical Treatment of Critical Limb Ischemia.
    Zimmermann A; Balk S; Kuehnl A; Eckstein HH
    Ann Vasc Surg; 2019 Feb; 55():104-111. PubMed ID: 30287288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Year Results of First-Line Treatment Strategies in Patients With Critical Limb Ischemia (CRITISCH Registry).
    Stavroulakis K; Borowski M; Torsello G; Bisdas T;
    J Endovasc Ther; 2018 Jun; 25(3):320-329. PubMed ID: 29968501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of ERICVA Risk Score as a Predictor of One Year Amputation-Free Survival of Patients with Critical Limb Ischemia.
    Mohamed SA; Viknaswaran NL; Doran J; Sanz-Nogués C; Ahmed K; Howard L; Tubassam M; O'Brien T; Walsh SR
    Ann Vasc Surg; 2021 Aug; 75():171-178. PubMed ID: 33819592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia.
    McPhee JT; Nguyen LL; Ho KJ; Ozaki CK; Conte MS; Belkin M
    J Vasc Surg; 2013 Jun; 57(6):1481-8. PubMed ID: 23395204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of an elevated neutrophil-lymphocyte ratio in the amputation-free survival of patients with chronic critical limb ischemia.
    González-Fajardo JA; Brizuela-Sanz JA; Aguirre-Gervás B; Merino-Díaz B; Del Río-Solá L; Martín-Pedrosa M; Vaquero-Puerta C
    Ann Vasc Surg; 2014 May; 28(4):999-1004. PubMed ID: 24559786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia.
    Chung J; Timaran DA; Modrall JG; Ahn C; Timaran CH; Kirkwood ML; Baig MS; Valentine RJ
    J Vasc Surg; 2013 Oct; 58(4):972-80. PubMed ID: 23993439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors analysis of thromboembolectomy for acute thromboembolic lower extremity ischemia in native arteries.
    Piffaretti G; Angrisano A; Franchin M; Ferrario M; Rivolta N; Bacuzzi A; Castelli P; Tozzi M
    J Cardiovasc Surg (Torino); 2018 Dec; 59(6):810-816. PubMed ID: 27901322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.